Glassman Wealth Services’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Glassman Wealth Services’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-241	Closed	-$976	–	1968
2023 Q4	$976	Hold	241	–	–	﹤0.01%	1557
2023 Q3	$648	Buy	+241	New	+$945	﹤0.01%	1674

Glassman Wealth Services's THRX Position: Q1 2024 in Review

Glassman Wealth Services sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 241 shares — an estimated $976 sold.

Glassman Wealth Services first reported a position in THRX in Q3 2023 and held it in 2 quarters. The position peaked at $976 in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Glassman Wealth Services reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Glassman Wealth Services sold 241 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $976.
Glassman Wealth Services first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Glassman Wealth Services's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $976 in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.